Ebpay生命医药出版社

Ebpay生命

100763

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

STAT6、ERG 和 miR-647 高表达作为前列腺癌的预测性生物标志物

 

Authors Yuan HZ, Jin SM, Yang WD, Du M, Wang L, Xiao L

Received 27 December 2024

Accepted for publication 11 March 2025

Published 10 April 2025 Volume 2025:18 Pages 2067—2075

DOI http://doi.org/10.2147/IJGM.S512606

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Leonardo O. Reis

Hua-Zun Yuan,1,* Sheng-Ming Jin,2,3,* Wen-Dong Yang,4,* Min Du,1 Lei Wang,1 Li Xiao1 

1Department of Pathology, Huadong Hospital, Fudan University, Shanghai, People’s Republic of China; 2Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 3Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China; 4Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu Province, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Li Xiao, Department of Pathology, Huadong Hospital, Fudan University, No. 221 West Yan’an Road, Shanghai, People’s Republic of China, Tel +86-18916615822, Email fangjx0207@foxmail.com

Aim: The aim of this study was to investigate the clinical significance of STAT6, ERG, miR-647 in prostate cancer (PCa).
Methods: This was a retrospective study. There were 210 consecutive patients diagnosed with prostate cancer or benign prostatic hyperplasia in our hospital from July 2020 to July 2023. Among those patients, 108 patients pathologically diagnosed as prostate cancer were divided into the prostate cancer group (PCa group), and 102 patients pathologically diagnosed as having benign prostatic hyperplasia were divided into the benign prostatic hyperplasia group (BPH group).
Results: The levels of STAT6 mRNA, ERG mRNA, and miR-647 expression in prostate cancer tissue were higher than those in BPH tissues, with statistically significant differences (P< 0.05) . The levels of STAT6 mRNA, ERG mRNA, and miR-647 indicators in prostate cancer patients were not significantly different with respect to patient age and tumor size (P > 0.05) but were related to lymph node metastasis, T stage, and Gleason score (P < 0.05). On the other hand, the tPSA/fPSA had significantly different between two groups (P < 0.05). PCa group had smaller MRI sagittal diameter and anteroposterior diameter in comparison to BPH group (P < 0.05), furthermore, PCa group had larger PI-RAD in comparison to BPH group (P < 0.05).
Conclusion: The higher level of STAT6, ERG, and miR-647 in prostate tissue are closely related to the occurrence of prostate cancer and have certain value in predicting the onset of prostate cancer.

Keywords: prostate cancer, signal transducer and activator of transcription 6, ETS-related gene, miR-647, Prostate cancer

Download Article[PDF]